Incyte Corp (INCY): EPS (Basic)
$6.59
Year ended 2025-12-31
+62.7%
3-year compound annual growth
n/m
10-year compound annual growth
| Period ended | EPS (Basic) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $6.59 | n/m | 2026-02-10, From 2025-01-01 |
| 2024-12-31 | $0.16 | -94.0% | 2026-02-10, From 2024-01-01 |
| 2023-12-31 | $2.67 | +74.5% | 2026-02-10, From 2023-01-01 |
| 2022-12-31 | $1.53 | -64.4% | 2025-02-10, From 2022-01-01 |
| 2021-12-31 | $4.30 | n/m | 2024-02-13, From 2021-01-01 |
| 2020-12-31 | -$1.36 | n/m | 2023-02-07, From 2020-01-01 |
| 2019-12-31 | $2.08 | +300.0% | 2022-02-08, From 2019-01-01 |
| 2018-12-31 | $0.52 | n/m | 2021-02-09, From 2018-01-01 |
| 2017-12-31 | -$1.53 | n/m | 2020-02-13, From 2017-01-01 |
| 2016-12-31 | $0.55 | n/m | 2019-02-14, From 2016-01-01 |
| 2015-12-31 | $0.04 | n/m | 2018-02-15, From 2015-01-01 |
| 2014-12-31 | -$0.29 | n/m | 2017-02-14, From 2014-01-01 |
| 2013-12-31 | -$0.56 | n/a | 2016-02-12, From 2013-01-01 |
EPS (Basic) at similar companies
| Company | Year ended | EPS (Basic) | Change YoY |
|---|---|---|---|
| Incyte Corp (INCY) | 2025-12-31 | $6.59 | n/m |
| Charles River Laboratories International, Inc. (CRL) | 2025-12-27 | -$2.91 | n/m |
| Icon PLC (ICLR) | 2025-12-31 | $2.92 | -67.4% |
| Medpace Holdings, Inc. (MEDP) | 2025-12-31 | $15.64 | +19.8% |
| Iqvia Holdings Inc. (IQV) | 2025-12-31 | $7.91 | +4.5% |
| NRC Health (NRC) | 2025-12-31 | $50.00 | n/m |
| MaxCyte, Inc. (MXCT) | 2025-12-31 | -$0.42 | n/m |
| OmniAb, Inc. (OABI) | 2025-12-31 | -$0.57 | n/m |
| bioAffinity Technologies, Inc. (BIAF) | 2025-12-31 | -$8.66 | n/m |
Compare INCY, CRL, ICLR, MEDP side by side · Screen every company in Services-Commercial Physical & Biological Research ↗